Cystic fibrosis: evidence for gut inflammation.

[1]  R. D. De Lisle,et al.  The cystic fibrosis intestine. , 2013, Cold Spring Harbor perspectives in medicine.

[2]  Maarten Bekaert,et al.  Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[3]  Eoin L. Brodie,et al.  Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota , 2013, Gut microbes.

[4]  C. Y. Ooi,et al.  Update of Faecal Markers of Inflammation in Children with Cystic Fibrosis , 2012, Mediators of inflammation.

[5]  Richard A. Flavell,et al.  Inflammasomes in health and disease , 2012, Nature.

[6]  Maarten Bekaert,et al.  Cross-Sectional and Longitudinal Comparisons of the Predominant Fecal Microbiota Compositions of a Group of Pediatric Patients with Cystic Fibrosis and Their Healthy Siblings , 2011, Applied and Environmental Microbiology.

[7]  R. D. De Lisle,et al.  Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype , 2010, BMC gastroenterology.

[8]  C. Haston,et al.  Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[9]  D. Vilozni,et al.  Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: A pilot study , 2010, Pediatric pulmonology.

[10]  H. Mussaffi,et al.  Evidence of Intestinal Inflammation in Patients With Cystic Fibrosis , 2010, Journal of pediatric gastroenterology and nutrition.

[11]  R. D. De Lisle,et al.  Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[12]  J. Escher,et al.  Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator. , 2009, Gastroenterology.

[13]  R. D. De Lisle,et al.  Altered Eicosanoid Metabolism in the Cystic Fibrosis Mouse Small Intestine , 2008, Journal of pediatric gastroenterology and nutrition.

[14]  H. Quinton,et al.  Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. , 2008, Journal of the American Dietetic Association.

[15]  R. D. De Lisle,et al.  Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[16]  R. Lisle.  Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine , 2007 .

[17]  V. Raia,et al.  Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. , 2007, Clinical nutrition.

[18]  Karin Noaksson,et al.  Increased levels of mucins in the cystic fibrosis mouse small intestine, and modulator effects of the Muc1 mucin expression. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[19]  R. D. De Lisle,et al.  Eradication of Small Intestinal Bacterial Overgrowth in the Cystic Fibrosis Mouse Reduces Mucus Accumulation , 2006, Journal of pediatric gastroenterology and nutrition.

[20]  J. Cuppoletti,et al.  SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents. , 2004, American journal of physiology. Cell physiology.

[21]  R. D. De Lisle,et al.  Bacterial Overgrowth in the Cystic Fibrosis Transmembrane Conductance Regulator Null Mouse Small Intestine , 2004, Infection and Immunity.

[22]  V. Raia,et al.  Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration , 2004, Alimentary pharmacology & therapeutics.

[23]  A. Ferrando,et al.  Decreased expression of peroxisome proliferator activated receptor γ in CFTR−/− mice , 2004 .

[24]  R. D. De Lisle,et al.  Inflammation of the cystic fibrosis mouse small intestine. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[25]  C. Cotton,et al.  Changes in the exocrine pancreas secondary to altered small intestinal function in the CF mouse. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[26]  L. Yu,et al.  Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress , 2001, Immunological reviews.

[27]  A. Ferguson,et al.  Intestinal inflammation in cystic fibrosis , 2000, Archives of disease in childhood.

[28]  V. Deretic,et al.  Innate Lung Defenses and Compromised Pseudomonas aeruginosa Clearance in the Malnourished Mouse Model of Respiratory Infections in Cystic Fibrosis , 2000, Infection and Immunity.

[29]  V. Raia,et al.  Evidence of Chronic Inflammation in Morphologically Normal Small Intestine of Cystic Fibrosis Patients , 2000, Pediatric Research.

[30]  L. Gawenis,et al.  Increased survival of CFTR knockout mice with an oral osmotic laxative. , 1996, Laboratory animal science.

[31]  G. Downey,et al.  Cystic fibrosis mouse models. , 2007, American journal of respiratory cell and molecular biology.

[32]  F. Collins,et al.  Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. , 1994, The Journal of clinical investigation.